Centro Internacional de Estudios Clínicos - CIEC

Centro de investigación en Dermatología y Reumatología
logoCentro Internacional de Estudios Clínicos - CIEC
Calle Manzano 343, Oficina 410-411, Comuna de Recoleta, Región Metropolitana, 8420383
Select an option
Our team
Medical staff
Fernando Valenzuela Ahumada
Director Médico - Investigador PrincipalFernando Valenzuela Ahumada
Dermatólogo con 15 años de experiencia en Investigación clínica.
Pablo Santa María
Sub-InvestigadorPablo Santa María
Dermatólogo con 10 años de experiencia en Investigación clínica.
Raúl  De la Fuente
Sub-InvestigadorRaúl De la Fuente
Dermatólogo con 5 años de experiencia en Investigación Clínica
Roberto  Bustos
Sub-InvestigadorRoberto Bustos
Dermatólogo con 5 años de experiencia en Investigación clínica
Karen  Vergara
Sub-InvestigadorKaren Vergara
Reumatóloga con 5 años de experiencia en Investigación clínica
Nicolás Moya
Sub-InvestigadorNicolás Moya
Dermatólogo con 5 años de experiencia en Investigación clínica
Silvana Saavedra
Sub-InvestigadorSilvana Saavedra
Reumatóloga con 5 años de experiencia en Investigación clínica
María Francisca Bozan
Investigador PrincipalMaría Francisca Bozan
Reumatóloga con 10 años de experiencia en Investigación clínica
Open studies
Lupus
A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy - AMETHYST - BiogenSee more
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus - SELECT-SLE - AbbVieSee more
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) - Merck Sharp & Dohme LLCSee more
Dermatitis
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis - COAST 1 - SanofiSee more
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor - AQUA - SanofiSee more
Alopecia
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants with Severe Alopecia Areata - Up-AA - AbbVieSee more
Arthritis
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis - SELECT- SWITCH - AbbVieSee more
Diffuse sclerosis
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms - VITALISScE™ - Boehringer IngelheimSee more
Prurigo nodularis
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) - TRuE-PN1 - Incyte CorporationSee more
Centro Internacional de Estudios Clínicos - CIEC
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy